Microbot Medical Inc. Announces Investor Briefing Conference Call and Webcast
March 29 2017 - 4:01PM
Microbot Medical Inc. (Nasdaq:MBOT), a medical device company
specializing in the design and development of transformational
micro-robotic medical technologies, announced today that it will
host an investor briefing conference call and webcast on Thursday,
April 6, 2017, at 10:00 a.m. ET. At this briefing, Microbot’s
management will review the Company’s business strategy and product
development pipeline, as disclosed in the company’s 10-K, which was
filed on March 21, 2017. Participants are welcome to submit
questions to management that may be answered during the Q&A
portion of the call, via email to aprior@evcgroup.com.
For both “listen-only” participants and those
participants who wish to take part in the question-and-answer
portion of the call, the dial-in number is 888-437-9364
(U.S./Canada) or 719-457-2643 (international) and providing the
Conference ID 9649093. A live webcast and subsequent archived
replay of the Company’s presentation may be accessed via the
‘Investors’ section, under ‘Presentations and Resources’ of the
Company’s website at www.microbotmedical.com.
A replay of the conference call will be
available for seven business days beginning about two hours after
the conclusion of the live call, by dialing 888-203-1112
(U.S./Canada) or +1 719-457-0820 (international) and providing the
Conference ID 9649093. An archived webcast will also be
available and may be accessed in the ‘Investors’ section of the
Company’s website at www.microbotmedical.com.
About Microbot Medical,
Inc.
Microbot, which was founded in 2010 and
commenced operations in 2011, became a NASDAQ listed company on
November 28, 2016. The Company specializes in transformational
micro-robotic medical technologies leveraging the natural and
artificial lumens within the human body. Microbot’s current
platforms, ViRob and TipCAT, are comprised of two highly advanced
micro-robotic technologies, from which the Company is currently
developing its first two product candidates: the Self Cleaning
Shunt, or SCS, for the treatment of hydrocephalus and Normal
Pressure Hydrocephalus, or NPH; and a self-propelling,
semi-disposable endoscope that is being developed initially for use
in colonoscopy procedures. Further information about Microbot
Medical is available at http://www.microbotmedical.com.
The ViRob technology is a revolutionary
autonomous crawling micro-robot which can be controlled remotely or
within the body. Its miniature dimensions allow it to
navigate and crawl in different spaces within the human body,
including blood vessels, the digestive tract and the respiratory
system. Its unique structure gives it the ability to move in
tight spaces and curved passages as well as the ability to remain
within the human body for prolonged time. To learn more about
ViRob please visit
http://www.microbotmedical.com/technology/virob/.
TipCAT is a transformational self-propelled,
flexible, and semi-disposable endoscope providing see & treat
capabilities within tubular lumens in the human body such as the
colon, blood vessels, and the urinary tract. Its locomotion
mechanism is perfectly suitable to navigate and crawl through
natural & artificial tubular lumens, applying the minimal
necessary pressure to achieve the adequate friction required for
gentle, fast, and safe advancement within the human body. To
learn more about TipCAT visit
http://www.microbotmedical.com/technology/tipcat/.
Investor Contacts:
EVC Group
Michael Polyviou/Doug Sherk - Investors
mpolyviou@evcgroup.com; dsherk@evcgroup.com
(646) 445-4800
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Apr 2023 to Apr 2024